As shown in Figure 6D, CD20+ B cells, CD8+ cells, and CD8+TIM3+ cells tended to be closer to tumor cells in the non-recurrent/non-metastatic group compared to the recurrent/metastatic group, although this difference did not reach statistical significance (p > 0.05). The gene discussed is CD8A; the disease is neoplasm.